The Leadership Team at TILT Biotherapeutics is responsible for shaping the strategic direction of the company, overseeing the development of innovative cancer immunotherapy solutions. With a dual focus on business strategy and medical expertise, the team works collaboratively to drive preclinical research, secure funding, and foster partnerships that advance TILT's mission to improve cancer treatment outcomes.
View all